1. Home
  2. NSPR vs SRFM Comparison

NSPR vs SRFM Comparison

Compare NSPR & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • SRFM
  • Stock Information
  • Founded
  • NSPR 2005
  • SRFM 2011
  • Country
  • NSPR Israel
  • SRFM United States
  • Employees
  • NSPR N/A
  • SRFM N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • SRFM Transportation Services
  • Sector
  • NSPR Health Care
  • SRFM Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • SRFM Nasdaq
  • Market Cap
  • NSPR 63.0M
  • SRFM 62.8M
  • IPO Year
  • NSPR N/A
  • SRFM 2023
  • Fundamental
  • Price
  • NSPR $2.93
  • SRFM $3.34
  • Analyst Decision
  • NSPR Strong Buy
  • SRFM Hold
  • Analyst Count
  • NSPR 2
  • SRFM 2
  • Target Price
  • NSPR $4.75
  • SRFM $3.40
  • AVG Volume (30 Days)
  • NSPR 78.6K
  • SRFM 625.6K
  • Earning Date
  • NSPR 11-12-2024
  • SRFM 11-14-2024
  • Dividend Yield
  • NSPR N/A
  • SRFM N/A
  • EPS Growth
  • NSPR N/A
  • SRFM N/A
  • EPS
  • NSPR N/A
  • SRFM N/A
  • Revenue
  • NSPR $6,821,000.00
  • SRFM $118,212,000.00
  • Revenue This Year
  • NSPR $13.31
  • SRFM $102.41
  • Revenue Next Year
  • NSPR $52.91
  • SRFM $47.46
  • P/E Ratio
  • NSPR N/A
  • SRFM N/A
  • Revenue Growth
  • NSPR 24.70
  • SRFM 198.78
  • 52 Week Low
  • NSPR $1.81
  • SRFM $0.90
  • 52 Week High
  • NSPR $3.42
  • SRFM $11.83
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 52.69
  • SRFM 49.61
  • Support Level
  • NSPR $2.78
  • SRFM $2.76
  • Resistance Level
  • NSPR $3.15
  • SRFM $4.50
  • Average True Range (ATR)
  • NSPR 0.22
  • SRFM 0.82
  • MACD
  • NSPR -0.03
  • SRFM -0.15
  • Stochastic Oscillator
  • NSPR 47.58
  • SRFM 16.43

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

Share on Social Networks: